✦ LIBER ✦

Improving chemotherapeutic drug penetration in melanoma by imatinib mesylate

✍ Scribed by Ogawa, Youichi; Kawamura, Tatsuyoshi; Furuhashi, Masao; Tsukamoto, Katsuhiko; Shimada, Shinji

Book ID: 119293369
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 727 KB
Volume: 51
Category: Article
ISSN: 0923-1811
DOI: 10.1016/j.jdermsci.2008.03.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Imatinib mesylate in combination with ot

Imatinib mesylate in combination with other chemotherapeutic drugs: In vitro studies

✍ Alex J. Tipping; Junia V. Melo 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Improving drug penetration in tumors by

Improving drug penetration in tumors by targeting tumor vascularization

✍ Ferdy J. Lejeune 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 327 KB

Significant improvement of right ventric

Significant improvement of right ventricular function by imatinib mesylate in scleroderma-associated pulmonary arterial hypertension

✍ Henrik ten Freyhaus; Daniel Dumitrescu; Henning Bovenschulte; Erland Erdmann; St 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 183 KB

Erythropoietin is effective in improving

Erythropoietin is effective in improving the anemia induced by imatinib mesylate therapy in patients with chronic myeloid leukemia in chronic phase

✍ Jorge Cortes; Susan O'Brien; Alfonso Quintas; Francis Giles; Jianquin Shan; Mary 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 1 views

## Abstract ## BACKGROUND Myelosuppression occurs in up to 50% of patients with chronic myeloid leukemia (CML) who are treated with imatinib and ≥ Grade 3 myelosuppression is reported in approximately 10% of patients. ## METHODS The authors investigated the prognostic significance of anemia occu